Reproductive BioMedicine Online (2019 IF: 3.218) covers the formation, growth and differentiation of the human embryo. It is intended to bring to public attention new research on biological and clinical research on human reproduction and the human embryo including relevant studies on animals. It is published by a group of scientists and clinicians working in these fields of study. Its audience comprises researchers, clinicians, practitioners, academics and patients.
The period of human embryonic growth covered is between the formation of the primordial germ cells in the fetus until mid-pregnancy. High quality research on lower animals is included if it helps to clarify the human situation. Studies progressing to birth and later are published if they have a direct bearing on events in the earlier stages of pregnancy.
Reproductive BioMedicine Online: articles in press and current issue
- Ferroptosis-resistance mechanisms in endometriosis for diagnostic model establishment
- Elective egg freezing and women's emancipation
- Fatty acid supplementation in warming solutions: Effects on the developmental competence of mouse, bovine, and human oocytes and embryos after vitrification
- Smartphone based lifestyle coaching programme ‘Smarter Pregnancy’ modifies behaviours in women with subfertility or recurrent miscarriage who are planning a pregnancy: A Randomised Controlled Trial
- Donor conception: How demographics and disclosure experiences impact donor-conceived adults’ motivations for seeking information about, and contact with, sperm donors
- Monochorionic twins after single embryo transfer with a blastocyst: a pilot study on a retrospective cohort and blinded time lapse annotation analysis
- Patient Burden and Healthcare Resource Utilization of Regimens for Controlled Ovarian Stimulation in Women Undergoing In-Vitro Fertilization: A Multi-national Observational Study from Europe and Asia-Pacific
- Karyotype of first clinical miscarriage and prognosis of subsequent pregnancy outcome
- Retrospective outcome in women aged 45 years and older undergoing natural cycle IVF treatment
- Editorial Board
- Association between arthritis treatments and ovarian reserve: a prospective study
- 16S rRNA long-read nanopore sequencing is feasible and reliable for endometrial microbiome analysis
- Stress and depression among women and men with recurrent pregnancy loss: Focusing both on the male and the female partner
- 2008 financial crisis vs 2020 economic fallout: How COVID-19 might influence fertility treatment and live births
- Safety of oil-based contrast medium for hysterosalpingography: a systematic review
- Genetic Testing of Products of Conception in Recurrent Pregnancy Loss Evaluation.
- Fibroids and natural fertility: a systematic review and meta-analysis
- The exogenous progesterone-free luteal phase: Two pilot randomized controlled trials in IVF patients
- Cumulative IVF outcomes following retrieval of testicular spermatozoa: should we use immotile sperm for ICSI?
- Reproductive risks and preimplantation genetic testing intervention for X-autosome translocation carriers
- Fibrin clot properties among women with endometriosis and the impact of ovarian stimulation
- Clusters of smooth endoplasmic reticulum are absent in oocytes from unstimulated women: data from comprehensive morphological analysis of ex vivo collected oocytes after IVM
- Serum AMH levels are not associated with aneuploidy rates in human blastocysts
- Disturbed progesterone signalling in an advanced preclinical model of endometriosis
- Corrigendum to ‘Comparing 36.5°C with 37°C for human embryoculture: a prospective randomized controlled trial’ [Reproductive BioMedicine Online 36 (2018) 620-626]
- Natural cycles in frozen-thawed embryo transfer are associated with lower risks of preeclampsia and large-for-gestational-age infants than artificial cycles: A systematic review and meta-analysis
- Deep learning neural network analysis of human blastocyst expansion from time-lapse image files
- Which factors affect the likelihood of miscarriage after single euploid blastocyst transfer?
- Absence of SARS-CoV-2 (COVID-19 virus) within the IVF laboratory using strict patient screening and safety criteria